284 related articles for article (PubMed ID: 37935403)
41. Detection of gene mutation in the prognosis of a patient with arrhythmogenic right ventricular cardiomyopathy: a case report.
Phan DP; Tran TV; Le VK; Nguyen TV
J Med Case Rep; 2024 Feb; 18(1):49. PubMed ID: 38336791
[TBL] [Abstract][Full Text] [Related]
42. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy.
Baudinaud P; Laredo M; Badenco N; Rouanet S; Waintraub X; Duthoit G; Hidden-Lucet F; Redheuil A; Maupain C; Gandjbakhch E
Can J Cardiol; 2021 Aug; 37(8):1263-1266. PubMed ID: 33675936
[TBL] [Abstract][Full Text] [Related]
43. Arrhythmogenic right ventricular dysplasia: from genetics to treatment.
Khan A; Mittal S; Sherrid MV
Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():24-31. PubMed ID: 20089484
[TBL] [Abstract][Full Text] [Related]
44. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies.
Corrado D; Basso C; Nava A; Thiene G
Cardiol Rev; 2001; 9(5):259-65. PubMed ID: 11520449
[TBL] [Abstract][Full Text] [Related]
45. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
Protonotarios A; Bariani R; Cappelletto C; Pavlou M; García-García A; Cipriani A; Protonotarios I; Rivas A; Wittenberg R; Graziosi M; Xylouri Z; Larrañaga-Moreira JM; de Luca A; Celeghin R; Pilichou K; Bakalakos A; Lopes LR; Savvatis K; Stolfo D; Dal Ferro M; Merlo M; Basso C; Freire JL; Rodriguez-Palomares JF; Kubo T; Ripoll-Vera T; Barriales-Villa R; Antoniades L; Mogensen J; Garcia-Pavia P; Wahbi K; Biagini E; Anastasakis A; Tsatsopoulou A; Zorio E; Gimeno JR; Garcia-Pinilla JM; Syrris P; Sinagra G; Bauce B; Elliott PM
Eur Heart J; 2022 Aug; 43(32):3053-3067. PubMed ID: 35766183
[TBL] [Abstract][Full Text] [Related]
46. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
[TBL] [Abstract][Full Text] [Related]
47. The pivotal role of compelling high-risk electrocardiographic markers in prediction of ventricular arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Iqbal M; Kamarullah W; Achmad C; Karwiky G; Akbar MR
Curr Probl Cardiol; 2024 Feb; 49(2):102241. PubMed ID: 38040211
[TBL] [Abstract][Full Text] [Related]
48. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Wang W; Orgeron G; Tichnell C; Murray B; Crosson J; Monfredi O; Cadrin-Tourigny J; Tandri H; Calkins H; James CA
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909402
[TBL] [Abstract][Full Text] [Related]
49. Arrhythmogenic right ventricular cardiomyopathy in the pediatric population.
Cohen MI; Atkins MB
Curr Opin Cardiol; 2022 Jan; 37(1):99-108. PubMed ID: 34857718
[TBL] [Abstract][Full Text] [Related]
50. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).
Hodgkinson KA; Parfrey PS; Bassett AS; Kupprion C; Drenckhahn J; Norman MW; Thierfelder L; Stuckless SN; Dicks EL; McKenna WJ; Connors SP
J Am Coll Cardiol; 2005 Feb; 45(3):400-8. PubMed ID: 15680719
[TBL] [Abstract][Full Text] [Related]
51. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
52. Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes.
Wang W; Gasperetti A; Sears SF; Tichnell C; Murray B; Tandri H; James CA; Calkins H
JACC Clin Electrophysiol; 2023 Mar; 9(3):394-402. PubMed ID: 36328892
[TBL] [Abstract][Full Text] [Related]
53. Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Orgeron GM; Crosson JE
Cardiol Young; 2017 Jan; 27(S1):S57-S61. PubMed ID: 28084951
[TBL] [Abstract][Full Text] [Related]
54. Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies.
González-Torrecilla E; Arenal A; Atienza F; Datino T; Bravo L; Ruiz P; Ávila P; Fernández-Avilés F
Rev Recent Clin Trials; 2015; 10(2):111-27. PubMed ID: 25845953
[TBL] [Abstract][Full Text] [Related]
55. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
Azaouagh A; Churzidse S; Konorza T; Erbel R
Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
[TBL] [Abstract][Full Text] [Related]
56. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
[TBL] [Abstract][Full Text] [Related]
57. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
58. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
[TBL] [Abstract][Full Text] [Related]
59. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
Europace; 2023 May; 25(5):. PubMed ID: 37213071
[TBL] [Abstract][Full Text] [Related]
60. Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy.
Corrado D; Buja G; Basso C; Thiene G
J Electrocardiol; 2000; 33 Suppl():49-55. PubMed ID: 11265736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
